— Know what they know.
Not Investment Advice

GKOS NYSE

Glaukos Corporation
1W: -2.1% 1M: +14.4% 3M: +15.7% YTD: +25.6% 1Y: +42.7% 3Y: +132.2% 5Y: +86.1%
$120.23
-18.80 (-13.52%)
 
Weekly Expected Move ±12.1%
$109 $127 $144 $161 $179
NYSE · Healthcare · Medical - Devices · Alpha Radar Neutral · Power 62 · $7.1B mcap · 56M float · 1.32% daily turnover · Short 57% of daily vol

📊 Key Metrics

TTM
$551M
Revenue
+36.3% YoY
$-189M
Net Income
-53.1% YoY
$-18M
Free Cash Flow
+65.3% YoY
77.9%
Gross Margin
-13.2%
Op. Margin
-13.1%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-26.6%
ROA-20.3%
ROIC-13.1%

Valuation

P/E-36.8
P/B10.4
EV/EBITDA-203.9

Leverage

Debt/Equity0.21
Current Ratio4.69
Interest Cov.-8.2x

Quality Scores

Piotroski F3/9
Altman Z15.17
Beneish M-2.95

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms